$2.87

-0.03 (-1.03%)
Live
Previous Close

$2.9

Day Range

$2.824 - $2.905

Previous Day Range

$2.81 - $2.9256

Market Cap

$88.4 million USD

Day Vol.

15123

Previous Day Vol.

45719

Currency

USD

Primary Exchange

Nasdaq

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on dev...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Wolf Haldenstein Adler Freeman & Herz LLP is investigating XBiotech for potential securities law violations after the company announced issues with its Phase II rheumatoid arthritis drug study, leading to a 29% stock price drop.

Related tickers: XBIT.

Read Full Article

XBiotech has suspended its clinical program on rheumatological conditions pending a review of the results from its recent Phase II study on rheumatoid arthritis. The study did not meet its primary endpoint due to substantial irregularities, and the company is now evaluating the implications of the results before deciding on the next steps for its Natrunix drug candidate in rheumatology.

Related tickers: XBIT.

Read Full Article
Trending Tickers

Please sign in to view